Alveolar Hemorrhage: A Rare Complication of Eptifibatide (Gl
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Acute coronary syndromes and myocardial infarction are often caused by platelet activation. Eptifibatide (Inte-grilin) is an antiplatelet agent that binds to the receptor of glycoprotein (GP) IIb/IIIa and leads to platelet aggre-gation inhibition (1). Percutaneous coronary interven-tion (PCI) is often preferred as the primary therapy (2).In previously published meta-analyses, the beneficial ef-fects of glycoprotein have supported (GP) IIb/IIIa in PCI(2). Several types of bleeding have been reported in asso-ciation with eptifibatide, however, alveolar hemorrhage remains a rare side effect of eptifibatide (3). In this casereport, we want to present this infrequent complication of eptifibatide....

http://bit.ly/2q0Ksi6
Dr. M●●●●●v D●●●i and 1 others like this
Like
Comment
Share